Myelodysplastic Syndromes (MDS)

Showing 1 - 25 of 34

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myelogenous Leukemia (CML) Trial in United States

Recruiting
  • Acute Myelogenous Leukemia (AML)
  • +5 more
  • Conditioning Chemotherapy
  • Cord blood graft
  • Basking Ridge, New Jersey
  • +6 more
May 22, 2023

MDS (MDS), Beta-thalassemia, Myeloproliferative Tumor(MPN)-Associated Myelofibrosis Trial in Worldwide (Luspatercept)

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Los Angeles, California
  • +203 more
Jan 30, 2023

MDS (MDS), Acute Myelogenous Leukemia (AML) Trial in United States (low dose 5'-azacitidine)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Acute Myelogenous Leukemia (AML)
  • low dose 5'-azacitidine
  • Basking Ridge, New Jersey
  • +6 more
Dec 1, 2022

Acute Myeloid Leukemia (AML), Acute Lymphoid Leukemia (ALL), MDS (MDS) Trial in New York (other, radiation, drug)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • +2 more
  • Personalized rATG (P-rATG)
  • +7 more
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Aug 31, 2022

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Beijing, Beijing, China
  • +13 more
Aug 16, 2022

MDS (MDS) Trial in United Kingdom (Sodium Valproate, Bezafibrate, Medroxyprogesterone, Danazol)

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • Sodium Valproate, Bezafibrate, Medroxyprogesterone
  • Danazol
  • Dudley, England, United Kingdom
  • +7 more
Aug 12, 2022

MDS (MDS) Trial in Worldwide (Azacitidine, Venetoclax)

Active, not recruiting
  • Myelodysplastic Syndromes (MDS)
  • Tucson, Arizona
  • +36 more
Aug 1, 2022

B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,

Not yet recruiting
  • B-Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 12, 2022

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Huddinge, Uppsala (NEX-18a injection,

Terminated
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • NEX-18a injection
  • Azacitidine Injection
  • Huddinge, Sweden
  • +1 more
Apr 4, 2022

The National Myelodysplastic Syndromes (MDS) Study

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • Therapeutic
  • Anaheim, California
  • +280 more
Apr 8, 2022

MDS (MDS) Trial in United States (Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine)

Completed
  • Myelodysplastic Syndromes (MDS)
  • Alvocidib Plus Decitabine (during dose escalation only) or Azacitidine
  • Chicago, Illinois
  • +11 more
Apr 4, 2022

Acute Myeloid Leukaemia (AML), MDS (MDS) Trial in Germany, Netherlands (Panobinostat)

Active, not recruiting
  • Acute Myeloid Leukaemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Stuttgart, Baden-Württemberg, Germany
  • +18 more
Dec 13, 2021

MDS (MDS) Trial in United States (Panobinostat)

Terminated
  • Myelodysplastic Syndromes (MDS)
  • Fort Myers, Florida
  • +6 more
Nov 18, 2021

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

MDS (MDS) Trial (Pevonedistat, Decitabine, Cedazuridine)

Withdrawn
  • Myelodysplastic Syndromes (MDS)
  • (no location specified)
Sep 23, 2021

Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021

Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Atlanta, Houston (K-NK002, Conditioning Regimen, HaploBMT)

Withdrawn
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • K-NK002
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jun 16, 2021

A Prospective, Multicentre European Registry for Newly Diagnosed

Recruiting
  • Myelodysplastic Syndromes (MDS)
  • No interventions
  • Innsbruck, Austria
  • +17 more
Dec 28, 2020

MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloid Leukemia (AML) Trial in Japan (Panobinostat)

Completed
  • Myelodysplastic Syndromes (MDS)
  • +2 more
  • Nagoya-city, Aichi, Japan
  • +5 more
Dec 16, 2020

Acute Lymphoblastic Leukaemias (ALL), Acute Myeloid Leukaemias (AML), MDS (MDS) Trial in Worldwide (Treosulfan)

Completed
  • Acute Lymphoblastic Leukaemias (ALL)
  • +3 more
  • Vienna, Austria
  • +23 more
Apr 30, 2020

Myelodysplastic Syndromes Under Different Treatment Modalities

Completed
  • Myelodysplastic Syndromes (MDS)
  • +4 more
    • Aachen, Germany
    • +12 more
    Feb 20, 2020

    MDS (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML) Trial in United States (Subcutaneous (SC)

    Completed
    • Myelodysplastic Syndromes (MDS)
    • +2 more
    • Subcutaneous (SC) Azacitidine
    • Oral Azacitidine
    • Gainesville, Florida
    • +17 more
    Nov 6, 2019

    Neural Tube Defects, Anemia, Leukemia, Myeloid Trial in Stanford (CIK cells, Cyclosporine, Mycophenolate Mofetil)

    Completed
    • Neural Tube Defects
    • +5 more
    • CIK cells
    • +4 more
    • Stanford, California
      Stanford University School of Medicine
    Apr 18, 2019

    MDS (MDS), Acute Myeloid Leukaemia (AML) Trial in Belgium, Germany, United Kingdom (Autologous WT1 TCR transduced T cells)

    Completed
    • Myelodysplastic Syndromes (MDS)
    • Acute Myeloid Leukaemia (AML)
    • Autologous WT1 TCR transduced T cells
    • Brugge, Belgium
    • +5 more
    Oct 1, 2018